Did Susan Collins sell Regeneron Pharmaceuticals stock?

Common questions

Did Susan Collins sell Regeneron Pharmaceuticals stock?

Yes. Susan Collins disclosed 1 sale of Regeneron Pharmaceuticals (REGN) stock on Jan 30, 2014, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Susan Collins's Regeneron Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Susan Collins make these Regeneron Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Susan Collins still own Regeneron Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Susan Collins report these trades?

The latest filing is dated Feb 5, 2014. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.